Lymphocutaneous sporotrichosis is a fungal infection caused by the Sporothrix schenckii species, typically acquired through skin trauma. It presents with nodular lesions that can ulcerate and is significant for its potential to spread along lymphatic pathways. Accurate coding with ICD-10 Code B42.1 is essential for proper diagnosis, documentation, billing, and public health reporting, ensuring that healthcare providers can effectively manage and track this condition.
ICD-10 Code B42.1 specifically denotes Lymphocutaneous sporotrichosis, a localized form of sporotrichosis characterized by skin lesions and lymphatic involvement. This code should be utilized in clinical documentation when a patient presents with symptoms consistent with this fungal infection, facilitating accurate billing and ensuring appropriate treatment protocols are followed.
Lymphocutaneous sporotrichosis is primarily caused by the fungus Sporothrix schenckii, often entering through skin abrasions. The condition can progress to involve the lymphatic system, leading to significant morbidity if untreated. Prompt medical attention is crucial to prevent complications and manage symptoms effectively.
ICD-10 Code B42.1 is utilized in SOAP notes to document the clinical presentation, assessment, and treatment of Lymphocutaneous sporotrichosis. This code aids in capturing the patient's symptoms, guiding the assessment process, and formulating a treatment plan, relevant in both acute and chronic care settings.
In SOAP notes, ICD-10 Code B42.1 connects subjective reports of symptoms with objective clinical findings, facilitating a formal diagnosis. This code is vital for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Lymphocutaneous sporotrichosis requires timely intervention to prevent complications. Hospitalization may be necessary for severe cases, and appropriate antifungal therapy is critical.
HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code B42.1 is crucial for billing in hospital, ER, or infectious disease settings, ensuring accurate claims processing.
CPT Code | Description |
---|---|
99213 | Established patient office visit, Level 3 |
17000 | Destruction of benign skin lesions, up to 14 lesions |
36415 | Collection of venous blood by venipuncture |
Common Questions About Using ICD-10 Code B42.1 for Lymphocutaneous sporotrichosis
What are the common symptoms of Lymphocutaneous sporotrichosis?
Common symptoms include nodular lesions that may ulcerate, localized pain, and swelling along lymphatic pathways. Patients may also report a history of exposure to soil or plant material.
How is Lymphocutaneous sporotrichosis treated?
Treatment typically involves antifungal medications such as itraconazole or fluconazole for several months, along with supportive care for symptom management.
Is Lymphocutaneous sporotrichosis contagious?
Lymphocutaneous sporotrichosis is not contagious; it is acquired through skin trauma from contaminated materials, primarily in outdoor environments.
When should ICD-10 Code B42.1 be used?
ICD-10 Code B42.1 should be used when a patient presents with symptoms consistent with lymphocutaneous sporotrichosis, ensuring accurate documentation and billing.
Clinical Notes
SOAP notes
DAP notes
AI medical notes